Looking forward to presenting a keynote at the ACS150 JACS Symposium Series: IACS Kolkata! I’ll be sharing insights from our work on macromolecular therapeutics as antiinfective agents! 📍 Kolkata, India | 📅 1 July 🔗 Find out more about this event: pubs.acs.org/JACS-Symposi...

Here is our editorial in ACS Infectious Diseases, focusing on combination therapy research published in ACS ID. The articles here highlight relevance of multipronged combination therapy as key to our fight against infection across pathogens. shorturl.at/sRGNW @pubs.acs.org @acs.org

Combination Therapy: A Pillar in the Fight Against Infectious Diseases

shorturl.at

2025 marks 80 years since the Nobel Prize for the verstile β-lactams! To celebrate this historic milestone, ACS ID invites contributions for a Special Issue. Read the Call for papers Editorial, also featuring insights from experts in the field! shorturl.at/ostfG @pubs.acs.org @acsbiol.bsky.social

In Recognition of the 80th Anniversary of Nobel Prize for Discovery of Penicillin: Call for Papers for a Special Issue

shorturl.at

Dec 2025 will mark 6 years since the first notification of COVID-19. Our Nov issue features an editorial from Scott Pegan, highlighting 25 diverse articles on COVID-19 published in ACS ID, over the last 5 years. pubs.acs.org/doi/10.1021/... @pubs.acs.org

Editorial: 5 Years of COVID Research: Highlights from Outbreak to the Present

This publication is free to access through this site. Learn More

pubs.acs.org

The November issue of #ACSInfectiousDiseases is now online. Highlighting key research in diagnostic and therapeutic strategies to tackle a wide range of pathogens. Read many interesting articles here: pubs.acs.org/toc/aidcbc/1... @pubs.acs.org @acsbiol.bsky.social

Make a nomination! The ACS ID Early Career Award is a collaboration between #ACSInfectiousDiseases @acsbiol.bsky.social recognizing three outstanding early career investigators in the field of infectious disease research (Deadline: Dec 1, 2025) shorturl.at/SxubM

Announcing a call for a special issue on Nontuberculous Mycobacterial (NTM) Pathogens, led by our guest editors Sidharth Chopra, Arunava Dasgupta and @lkremer1.bsky.social! Accepting manuscripts on various themes. Deadline - March 30, 2026. @pubs.acs.org Link - pubs.acs.org/doi/10.1021/...

Call for Papers: Nontuberculous Mycobacterial (NTM) Pathogens─Biology, Infection, and Drug Discovery

pubs.acs.org

Register now for this free webinar to gain critical insights into cutting-edge sepsis research in the field and to hear about recent advances in sepsis detection & treatment. We hope that you will join us on Sept 10! acs.org/acs-webinars... @pubs.acs.org #ACSInfectiousDiseases

Sepsis: Rethinking the Fight Against a Global Killer - American Chemical Society

Learn a brief history of the fight against sepsis and how metabolic adaptation and thermoregulation influence sepsis development.

acs.org

The One Health concept bridges different disciplines critical in addressing challenges posed by Vector Borne Parasitic Diseases. Explore this Special Issue in #ACSInfectiousDiseases highlighting diverse aspects of One Health approach. @pubs.acs.org shorturl.at/v775r

Thrilled to celebrate the outstanding recipients of the ACS Infectious Diseases Young Investigator Award at #ACSIDSymposium 2025! Their cutting-edge work is advancing frontiers of ID research. Here is a photo of the awardees with Prof. James Hougland. #ACSInfectiousDiseases

The latest issue of ACS ID is out! We have articles spanning Mycobacteria, Fungai, MDR bacteria such as A. baumannii, P. aeruginosa, S. Typhimurium, etc. They cover areas like molecular mechanisms, immunomodulatory strategies, diagnostics, etc. pubs.acs.org/toc/aidcbc/1... #ACSInfectiousDiseases

ACS Infectious Diseases

This study reports on the antiparasitic profiles of batzelladines F and L, which exhibited strong antiplasmodial activity, moderate cytotoxicity, and good selectivity indexes. Both compounds act quickly against resistant and clinical isolates of P. falciparum, with batzelladine F also showing in vivo activity in a P. berghei model. These findings support the development of guanidine alkaloid derivatives as promising candidates for malaria treatment. View the article.

pubs.acs.org

Happy to share our editorial honoring the legacy of Prof. Bill DeGrado (UCSF), a pioneer in the field, written along with Prof. Marcos Piers & Prof. Mike Klein! The editorial is accompanied by a written interview of Bill. Link: shorturl.at/43YoC @acs.org @pubs.acs.org

Honoring Prof. William (Bill) F. DeGrado: An Inspiring Journey of a Transformative Chemist

shorturl.at

Happy to share an the concluding editorial of our Fungal Pathogens special issue! A successful issue, with articles on different themes related to fungi. Here is the link to the special issue - pubs.acs.org/page/si/fung... #ACSInfectiousDiseases

Have a look at the thoughts by our guest editors & some authors who Contributed to the "Combatting Tuberculosis Special Issue" in recognition of World TB Day! It is only with the collective interdisciplinary efforts we can fight TB. #ACSInfectiousDiseases @pubs.acs.org shorturl.at/YV7be

ACS Infectious Diseases Commemorates World Tuberculosis Day 2025: Featured Interviews with Researchers | ACS Publications Chemistry Blog

In recognition of World Tuberculosis Day, held each year on March 24, we present a collection of interviews and research highlights from experts in the field who have published their work in ACS Infec...

shorturl.at

Wishing all a happy women's day! Proud to share that #ACSInfectiousDiseases has highlighted contributions of our women scientists in a collection. Our AE Helen Zgurskaya has written an editorial, with interviews by some of our contributors. @acs.org pubs.acs.org/page/aidcbc/...